

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 6.47230359 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.73542175 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.73542175 |
| 4 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.63641144 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.41757269 |
| 6 | glucosamine-containing compound catabolic process (GO:1901072) | 5.13715880 |
| 7 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.11917880 |
| 8 | hepatocyte apoptotic process (GO:0097284) | 4.93560288 |
| 9 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.71109365 |
| 10 | response to muramyl dipeptide (GO:0032495) | 4.46004045 |
| 11 | neutrophil mediated immunity (GO:0002446) | 4.44478939 |
| 12 | cellular extravasation (GO:0045123) | 4.38406774 |
| 13 | NIK/NF-kappaB signaling (GO:0038061) | 4.24861250 |
| 14 | negative regulation of growth of symbiont in host (GO:0044130) | 4.20309216 |
| 15 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 4.20309216 |
| 16 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 4.20309216 |
| 17 | regulation of growth of symbiont in host (GO:0044126) | 4.20309216 |
| 18 | negative regulation of interleukin-8 production (GO:0032717) | 4.17738718 |
| 19 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.15201181 |
| 20 | cellular response to zinc ion (GO:0071294) | 4.05886541 |
| 21 | innate immune response in mucosa (GO:0002227) | 3.98852499 |
| 22 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.97765868 |
| 23 | establishment of endothelial barrier (GO:0061028) | 3.93681331 |
| 24 | COPI coating of Golgi vesicle (GO:0048205) | 3.91399802 |
| 25 | Golgi transport vesicle coating (GO:0048200) | 3.91399802 |
| 26 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.90199237 |
| 27 | leukocyte mediated cytotoxicity (GO:0001909) | 3.87645185 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 3.85234425 |
| 29 | mannose metabolic process (GO:0006013) | 3.80846770 |
| 30 | epithelial structure maintenance (GO:0010669) | 3.80319771 |
| 31 | detection of other organism (GO:0098543) | 3.75772928 |
| 32 | regulation of mast cell degranulation (GO:0043304) | 3.75627940 |
| 33 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.68430057 |
| 34 | regulation of leukocyte degranulation (GO:0043300) | 3.64032252 |
| 35 | corticosteroid receptor signaling pathway (GO:0031958) | 3.63408867 |
| 36 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.55540064 |
| 37 | necroptotic process (GO:0070266) | 3.51354726 |
| 38 | respiratory burst (GO:0045730) | 3.49090167 |
| 39 | detection of bacterium (GO:0016045) | 3.47758319 |
| 40 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.45643287 |
| 41 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.45101985 |
| 42 | organ or tissue specific immune response (GO:0002251) | 3.44997073 |
| 43 | antibacterial humoral response (GO:0019731) | 3.44806003 |
| 44 | negative regulation of phagocytosis (GO:0050765) | 3.42649822 |
| 45 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.41002627 |
| 46 | myeloid leukocyte mediated immunity (GO:0002444) | 3.39629768 |
| 47 | antimicrobial humoral response (GO:0019730) | 3.38980465 |
| 48 | macrophage activation involved in immune response (GO:0002281) | 3.38824928 |
| 49 | negative regulation of interleukin-6 production (GO:0032715) | 3.38580022 |
| 50 | mucosal immune response (GO:0002385) | 3.37681403 |
| 51 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.34403047 |
| 52 | actin nucleation (GO:0045010) | 3.32864777 |
| 53 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.30789962 |
| 54 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.30789962 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.30731952 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 3.30147282 |
| 57 | O-glycan processing (GO:0016266) | 3.29624343 |
| 58 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.24683916 |
| 59 | megakaryocyte development (GO:0035855) | 3.23624015 |
| 60 | sequestering of metal ion (GO:0051238) | 3.22658305 |
| 61 | response to protozoan (GO:0001562) | 3.21846949 |
| 62 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.18298687 |
| 63 | intestinal absorption (GO:0050892) | 3.18004643 |
| 64 | regulation of mast cell activation (GO:0033003) | 3.17473134 |
| 65 | regulation of B cell differentiation (GO:0045577) | 3.16589403 |
| 66 | B cell receptor signaling pathway (GO:0050853) | 3.16319445 |
| 67 | T cell migration (GO:0072678) | 3.10723611 |
| 68 | germinal center formation (GO:0002467) | 3.10292587 |
| 69 | response to host immune response (GO:0052572) | 3.08674003 |
| 70 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.08674003 |
| 71 | leukocyte degranulation (GO:0043299) | 3.08218302 |
| 72 | defense response to fungus (GO:0050832) | 3.08061057 |
| 73 | peptide catabolic process (GO:0043171) | 3.07360358 |
| 74 | cell wall macromolecule catabolic process (GO:0016998) | 3.05634769 |
| 75 | neutrophil activation involved in immune response (GO:0002283) | 3.05556909 |
| 76 | angiotensin maturation (GO:0002003) | 3.04223005 |
| 77 | response to fungus (GO:0009620) | 3.03914856 |
| 78 | surfactant homeostasis (GO:0043129) | 3.03049161 |
| 79 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.02879405 |
| 80 | regulation of regulated secretory pathway (GO:1903305) | 2.98108678 |
| 81 | leukocyte aggregation (GO:0070486) | 2.97256713 |
| 82 | regulation of vitamin metabolic process (GO:0030656) | 2.96419200 |
| 83 | defense response to Gram-positive bacterium (GO:0050830) | 2.96359678 |
| 84 | amino sugar catabolic process (GO:0046348) | 2.95198461 |
| 85 | regulation of necroptotic process (GO:0060544) | 2.93419700 |
| 86 | neutrophil activation (GO:0042119) | 2.91967480 |
| 87 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.91781657 |
| 88 | mature B cell differentiation involved in immune response (GO:0002313) | 2.91274941 |
| 89 | regulation of RIG-I signaling pathway (GO:0039535) | 2.91171871 |
| 90 | positive regulation of mast cell activation (GO:0033005) | 2.90804617 |
| 91 | definitive hemopoiesis (GO:0060216) | 2.90361222 |
| 92 | negative regulation of T cell mediated immunity (GO:0002710) | 2.89855798 |
| 93 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.89588422 |
| 94 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.89332040 |
| 95 | positive regulation of mast cell degranulation (GO:0043306) | 2.88651417 |
| 96 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.88651417 |
| 97 | embryonic process involved in female pregnancy (GO:0060136) | 2.88211806 |
| 98 | phospholipid translocation (GO:0045332) | 2.88005799 |
| 99 | lipid translocation (GO:0034204) | 2.88005799 |
| 100 | histone H3-K36 demethylation (GO:0070544) | 2.87666962 |
| 101 | disruption of cells of other organism (GO:0044364) | 2.87003099 |
| 102 | killing of cells of other organism (GO:0031640) | 2.87003099 |
| 103 | myeloid dendritic cell activation (GO:0001773) | 2.85021326 |
| 104 | defense response to protozoan (GO:0042832) | 2.82126300 |
| 105 | regulation of interferon-alpha production (GO:0032647) | 2.81229835 |
| 106 | detection of external biotic stimulus (GO:0098581) | 2.79418413 |
| 107 | macrophage activation (GO:0042116) | 2.79070322 |
| 108 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.78621351 |
| 109 | detection of biotic stimulus (GO:0009595) | 2.77250649 |
| 110 | positive regulation of interferon-alpha production (GO:0032727) | 2.76753493 |
| 111 | positive regulation of granulocyte differentiation (GO:0030854) | 2.76630865 |
| 112 | microglial cell activation (GO:0001774) | 2.76456227 |
| 113 | positive regulation of macrophage differentiation (GO:0045651) | 2.75871070 |
| 114 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.75786598 |
| 115 | response to host (GO:0075136) | 2.75550961 |
| 116 | response to host defenses (GO:0052200) | 2.75550961 |
| 117 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.75550961 |
| 118 | myeloid dendritic cell differentiation (GO:0043011) | 2.74820180 |
| 119 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.74752982 |
| 120 | immunoglobulin mediated immune response (GO:0016064) | 2.72557013 |
| 121 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.72221281 |
| 122 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.71853200 |
| 123 | positive regulation of B cell differentiation (GO:0045579) | 2.71677455 |
| 124 | regulation of tumor necrosis factor production (GO:0032680) | 2.71005553 |
| 125 | positive regulation of interferon-beta production (GO:0032728) | 2.69898209 |
| 126 | cell killing (GO:0001906) | 2.66717585 |
| 127 | endothelial cell development (GO:0001885) | 2.66547753 |
| 128 | protein maturation by protein folding (GO:0022417) | 2.65326336 |
| 129 | negative regulation of granulocyte differentiation (GO:0030853) | 2.62827217 |
| 130 | dendritic cell differentiation (GO:0097028) | 2.62286630 |
| 131 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.62058347 |
| 132 | macrophage differentiation (GO:0030225) | 2.60682277 |
| 133 | pinocytosis (GO:0006907) | 2.59394124 |
| 134 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.58589754 |
| 135 | digestive system process (GO:0022600) | 2.58073616 |
| 136 | regulation of cellular extravasation (GO:0002691) | 2.55717811 |
| 137 | positive regulation of lamellipodium assembly (GO:0010592) | 2.54781624 |
| 138 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.53588835 |
| 139 | granulocyte activation (GO:0036230) | 2.52991028 |
| 140 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.52278486 |
| 141 | pentose-phosphate shunt (GO:0006098) | 2.51636933 |
| 142 | growth hormone receptor signaling pathway (GO:0060396) | 2.51281890 |
| 143 | angiogenesis involved in wound healing (GO:0060055) | 2.49478013 |
| 144 | intestinal epithelial cell development (GO:0060576) | 2.47611127 |
| 145 | dendritic cell migration (GO:0036336) | 2.47594100 |
| 146 | peptidyl-asparagine modification (GO:0018196) | 2.45707601 |
| 147 | leukotriene metabolic process (GO:0006691) | 2.45279256 |
| 148 | mature B cell differentiation (GO:0002335) | 2.45243081 |
| 149 | programmed necrotic cell death (GO:0097300) | 2.44193131 |
| 150 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.43725080 |
| 151 | NADPH regeneration (GO:0006740) | 2.41580038 |
| 152 | actin filament depolymerization (GO:0030042) | 2.40911900 |
| 153 | leukocyte cell-cell adhesion (GO:0007159) | 2.40895999 |
| 154 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.40387180 |
| 155 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.40387180 |
| 156 | modulation by symbiont of host immune response (GO:0052553) | 2.40387180 |
| 157 | positive regulation by symbiont of host defense response (GO:0052509) | 2.40387180 |
| 158 | modulation by symbiont of host defense response (GO:0052031) | 2.40387180 |
| 159 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.40387180 |
| 160 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.40084775 |
| 161 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.39645049 |
| 162 | positive regulation of antigen processing and presentation (GO:0002579) | 2.37447485 |
| 163 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.35810537 |
| 164 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.34636567 |
| 165 | regulation of gamma-delta T cell activation (GO:0046643) | 2.33223750 |
| 166 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.32919457 |
| 167 | natural killer cell mediated immunity (GO:0002228) | 2.32919457 |
| 168 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.32557472 |
| 169 | positive regulation of lamellipodium organization (GO:1902745) | 2.32102965 |
| 170 | cytokine secretion (GO:0050663) | 2.31525628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.47151869 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 5.12745268 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.60038137 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.41959325 |
| 5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.17920082 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.09937075 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.96091269 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.92961535 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.80187908 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.78193912 |
| 11 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.70272199 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65360052 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56226359 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.50672685 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.47771561 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.42637192 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.41291495 |
| 18 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.40111648 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.31982768 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.26295673 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.22680966 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22274116 |
| 23 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.21718791 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.12755729 |
| 25 | * MYB_26560356_Chip-Seq_TH2_Human | 2.08608197 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.00025809 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.99149716 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.93618495 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.91464225 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.87902286 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84725896 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.84059529 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81666780 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.80879381 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.79070459 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76369332 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.73348685 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.72962617 |
| 39 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.71180903 |
| 40 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.68182551 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67931379 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.62572644 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.61601866 |
| 44 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59219456 |
| 45 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.55142791 |
| 46 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.52403345 |
| 47 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.52058268 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.51272935 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46088504 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43084664 |
| 51 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.41417586 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40699389 |
| 53 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.39315569 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37147972 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36580486 |
| 56 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.36512846 |
| 57 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.36512846 |
| 58 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.36512846 |
| 59 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35944255 |
| 60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35595720 |
| 61 | GATA1_19941826_ChIP-Seq_K562_Human | 1.35526642 |
| 62 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.35354558 |
| 63 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35204203 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34682459 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34670892 |
| 66 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33871736 |
| 67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33676767 |
| 68 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33258364 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32426657 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30871308 |
| 71 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29033639 |
| 72 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26756346 |
| 73 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26745416 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.25827557 |
| 75 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25511955 |
| 76 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24916099 |
| 77 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.24332626 |
| 78 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23495966 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23135764 |
| 80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18926651 |
| 81 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.18440580 |
| 82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16590557 |
| 83 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15077343 |
| 84 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13765823 |
| 85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12852494 |
| 86 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10825060 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10426660 |
| 88 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10172707 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09883507 |
| 90 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09868409 |
| 91 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09661956 |
| 92 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08252705 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08076363 |
| 94 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07442085 |
| 95 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06906733 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05885453 |
| 97 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05611264 |
| 98 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03913556 |
| 99 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03558227 |
| 100 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03506214 |
| 101 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02989605 |
| 102 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01327581 |
| 103 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01205030 |
| 104 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01124801 |
| 105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00978301 |
| 106 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99461330 |
| 107 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99381056 |
| 108 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98937544 |
| 109 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97324284 |
| 110 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97054875 |
| 111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97011583 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96828701 |
| 113 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.96081954 |
| 114 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.95839746 |
| 115 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95621298 |
| 116 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95253829 |
| 117 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94901092 |
| 118 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.93947297 |
| 119 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93450226 |
| 120 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93122505 |
| 121 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91465084 |
| 122 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.91143826 |
| 123 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90845487 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89823810 |
| 125 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87476503 |
| 126 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86934598 |
| 127 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86934598 |
| 128 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.86796337 |
| 129 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86301751 |
| 130 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.85729846 |
| 131 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.82359487 |
| 132 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78925577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 4.01873912 |
| 2 | MP0001873_stomach_inflammation | 3.18471580 |
| 3 | MP0004264_abnormal_extraembryonic_tissu | 3.18434972 |
| 4 | MP0003300_gastrointestinal_ulcer | 2.93029794 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 2.84358648 |
| 6 | MP0008004_abnormal_stomach_pH | 2.71949997 |
| 7 | MP0003183_abnormal_peptide_metabolism | 2.62875039 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.38533681 |
| 9 | MP0003303_peritoneal_inflammation | 2.33888785 |
| 10 | MP0010155_abnormal_intestine_physiology | 2.29532982 |
| 11 | MP0005076_abnormal_cell_differentiation | 2.23750966 |
| 12 | MP0003436_decreased_susceptibility_to | 2.21730342 |
| 13 | MP0006082_CNS_inflammation | 2.20083811 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.12411597 |
| 15 | MP0000685_abnormal_immune_system | 2.09212958 |
| 16 | MP0003866_abnormal_defecation | 2.03969065 |
| 17 | MP0002396_abnormal_hematopoietic_system | 1.99147349 |
| 18 | MP0000490_abnormal_crypts_of | 1.97479268 |
| 19 | MP0002254_reproductive_system_inflammat | 1.95762633 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.95447841 |
| 21 | MP0003566_abnormal_cell_adhesion | 1.92395865 |
| 22 | MP0000569_abnormal_digit_pigmentation | 1.84249465 |
| 23 | * MP0002419_abnormal_innate_immunity | 1.83414145 |
| 24 | MP0009785_altered_susceptibility_to | 1.81680175 |
| 25 | MP0001666_abnormal_nutrient_absorption | 1.80172132 |
| 26 | * MP0005025_abnormal_response_to | 1.72927912 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.71098699 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.69986844 |
| 29 | MP0001663_abnormal_digestive_system | 1.68625474 |
| 30 | MP0001853_heart_inflammation | 1.67421076 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 1.65865016 |
| 32 | MP0004782_abnormal_surfactant_physiolog | 1.63833279 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 1.63550172 |
| 34 | MP0001800_abnormal_humoral_immune | 1.62239586 |
| 35 | MP0005451_abnormal_body_composition | 1.60892309 |
| 36 | MP0003724_increased_susceptibility_to | 1.57236880 |
| 37 | * MP0001819_abnormal_immune_cell | 1.55124842 |
| 38 | MP0001790_abnormal_immune_system | 1.54502703 |
| 39 | MP0005387_immune_system_phenotype | 1.54502703 |
| 40 | * MP0002420_abnormal_adaptive_immunity | 1.53901794 |
| 41 | MP0005464_abnormal_platelet_physiology | 1.52385368 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.51955342 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.50950683 |
| 44 | MP0004947_skin_inflammation | 1.50196273 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.49890741 |
| 46 | * MP0002148_abnormal_hypersensitivity_rea | 1.48518440 |
| 47 | MP0002006_tumorigenesis | 1.48292243 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.45322662 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.44294038 |
| 50 | MP0002723_abnormal_immune_serum | 1.42555569 |
| 51 | MP0002405_respiratory_system_inflammati | 1.40557034 |
| 52 | MP0005381_digestive/alimentary_phenotyp | 1.39674931 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.38206019 |
| 54 | MP0005000_abnormal_immune_tolerance | 1.38170902 |
| 55 | MP0000477_abnormal_intestine_morphology | 1.34914979 |
| 56 | MP0005310_abnormal_salivary_gland | 1.34539595 |
| 57 | MP0005174_abnormal_tail_pigmentation | 1.33360661 |
| 58 | * MP0002398_abnormal_bone_marrow | 1.32630060 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.25364018 |
| 60 | * MP0000716_abnormal_immune_system | 1.25082455 |
| 61 | MP0001664_abnormal_digestion | 1.25074132 |
| 62 | MP0000462_abnormal_digestive_system | 1.24957557 |
| 63 | MP0000858_altered_metastatic_potential | 1.22384271 |
| 64 | MP0001958_emphysema | 1.19111518 |
| 65 | MP0003705_abnormal_hypodermis_morpholog | 1.18325133 |
| 66 | MP0003172_abnormal_lysosome_physiology | 1.17856817 |
| 67 | MP0008260_abnormal_autophagy | 1.16985338 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.16267814 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.16267814 |
| 70 | MP0009840_abnormal_foam_cell | 1.15674292 |
| 71 | MP0003075_altered_response_to | 1.15254491 |
| 72 | MP0010678_abnormal_skin_adnexa | 1.13685947 |
| 73 | MP0010307_abnormal_tumor_latency | 1.12435684 |
| 74 | * MP0002429_abnormal_blood_cell | 1.11668956 |
| 75 | MP0002009_preneoplasia | 1.11316991 |
| 76 | MP0001881_abnormal_mammary_gland | 1.10812156 |
| 77 | MP0005671_abnormal_response_to | 1.09463227 |
| 78 | MP0000015_abnormal_ear_pigmentation | 1.07098792 |
| 79 | * MP0002722_abnormal_immune_system | 1.05801219 |
| 80 | MP0000689_abnormal_spleen_morphology | 1.01522608 |
| 81 | MP0005167_abnormal_blood-brain_barrier | 1.01386944 |
| 82 | MP0005166_decreased_susceptibility_to | 1.01151526 |
| 83 | MP0000537_abnormal_urethra_morphology | 1.00727436 |
| 84 | MP0001765_abnormal_ion_homeostasis | 0.95648164 |
| 85 | MP0002132_abnormal_respiratory_system | 0.94344636 |
| 86 | MP0003693_abnormal_embryo_hatching | 0.94331476 |
| 87 | MP0003091_abnormal_cell_migration | 0.92028254 |
| 88 | MP0004510_myositis | 0.91185668 |
| 89 | MP0008469_abnormal_protein_level | 0.90970447 |
| 90 | MP0003943_abnormal_hepatobiliary_system | 0.88384579 |
| 91 | MP0000470_abnormal_stomach_morphology | 0.88145751 |
| 92 | MP0003448_altered_tumor_morphology | 0.86341655 |
| 93 | MP0005164_abnormal_response_to | 0.85852807 |
| 94 | MP0001851_eye_inflammation | 0.85839301 |
| 95 | MP0009278_abnormal_bone_marrow | 0.84308623 |
| 96 | MP0003763_abnormal_thymus_physiology | 0.83460858 |
| 97 | MP0001879_abnormal_lymphatic_vessel | 0.82682248 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82604664 |
| 99 | MP0002933_joint_inflammation | 0.82492507 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.82331670 |
| 101 | MP0000383_abnormal_hair_follicle | 0.81440166 |
| 102 | MP0002019_abnormal_tumor_incidence | 0.81234808 |
| 103 | MP0003191_abnormal_cellular_cholesterol | 0.80314862 |
| 104 | MP0000343_altered_response_to | 0.80053527 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.78543694 |
| 106 | MP0008057_abnormal_DNA_replication | 0.78415866 |
| 107 | MP0009115_abnormal_fat_cell | 0.76464742 |
| 108 | MP0009333_abnormal_splenocyte_physiolog | 0.75549686 |
| 109 | MP0003453_abnormal_keratinocyte_physiol | 0.74433639 |
| 110 | MP0004883_abnormal_blood_vessel | 0.73956334 |
| 111 | MP0003111_abnormal_nucleus_morphology | 0.73461375 |
| 112 | MP0005390_skeleton_phenotype | 0.73397439 |
| 113 | MP0000249_abnormal_blood_vessel | 0.73146423 |
| 114 | MP0009764_decreased_sensitivity_to | 0.73003723 |
| 115 | MP0000604_amyloidosis | 0.72876496 |
| 116 | MP0009763_increased_sensitivity_to | 0.69875347 |
| 117 | MP0003828_pulmonary_edema | 0.68580227 |
| 118 | MP0000703_abnormal_thymus_morphology | 0.68393816 |
| 119 | MP0005023_abnormal_wound_healing | 0.67862944 |
| 120 | MP0005075_abnormal_melanosome_morpholog | 0.66706687 |
| 121 | MP0009931_abnormal_skin_appearance | 0.65936866 |
| 122 | MP0005647_abnormal_sex_gland | 0.65860850 |
| 123 | MP0003795_abnormal_bone_structure | 0.65360371 |
| 124 | MP0005319_abnormal_enzyme/_coenzyme | 0.64232920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Interstitial pulmonary disease (HP:0006530) | 4.27306545 |
| 2 | Thrombocytosis (HP:0001894) | 4.12745172 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.09041049 |
| 4 | Stomatitis (HP:0010280) | 4.06145644 |
| 5 | Recurrent cutaneous fungal infections (HP:0011370) | 3.96942251 |
| 6 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.96942251 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.77400771 |
| 8 | Acute lymphatic leukemia (HP:0006721) | 3.75992495 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.71479800 |
| 10 | Periodontitis (HP:0000704) | 3.65895131 |
| 11 | Chronic otitis media (HP:0000389) | 3.55963902 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 3.54561243 |
| 13 | Abnormality of B cell number (HP:0010975) | 3.42858353 |
| 14 | B lymphocytopenia (HP:0010976) | 3.39191206 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.37172056 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.28805298 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.28805298 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.28805298 |
| 19 | Amyloidosis (HP:0011034) | 3.25236434 |
| 20 | Recurrent viral infections (HP:0004429) | 3.23812216 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.19120761 |
| 22 | Granulocytopenia (HP:0001913) | 3.16737176 |
| 23 | Myositis (HP:0100614) | 3.12483358 |
| 24 | Retrobulbar optic neuritis (HP:0100654) | 3.06651944 |
| 25 | Optic neuritis (HP:0100653) | 3.06651944 |
| 26 | Cortical dysplasia (HP:0002539) | 3.05009084 |
| 27 | Fatigue (HP:0012378) | 2.88678938 |
| 28 | Spondylolisthesis (HP:0003302) | 2.86401318 |
| 29 | Abnormality of the fingertips (HP:0001211) | 2.83887605 |
| 30 | Thoracic kyphosis (HP:0002942) | 2.82723897 |
| 31 | Panhypogammaglobulinemia (HP:0003139) | 2.75569776 |
| 32 | Leukocytosis (HP:0001974) | 2.75328845 |
| 33 | Ileus (HP:0002595) | 2.75293568 |
| 34 | Neoplasm of head and neck (HP:0012288) | 2.75104160 |
| 35 | Esophageal neoplasm (HP:0100751) | 2.75104160 |
| 36 | Abnormality of macrophages (HP:0004311) | 2.74339921 |
| 37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.71335844 |
| 38 | IgM deficiency (HP:0002850) | 2.70506983 |
| 39 | Autoimmune thrombocytopenia (HP:0001973) | 2.70287929 |
| 40 | Right ventricular cardiomyopathy (HP:0011663) | 2.70160918 |
| 41 | Chronic diarrhea (HP:0002028) | 2.68881354 |
| 42 | Chest pain (HP:0100749) | 2.68377255 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.67887187 |
| 44 | Rectal prolapse (HP:0002035) | 2.67423730 |
| 45 | Colitis (HP:0002583) | 2.63774418 |
| 46 | Hematochezia (HP:0002573) | 2.61331584 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.59288438 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.57122230 |
| 49 | Gastrointestinal stroma tumor (HP:0100723) | 2.55990439 |
| 50 | Encephalitis (HP:0002383) | 2.55210966 |
| 51 | Aortic aneurysm (HP:0004942) | 2.54744130 |
| 52 | Conjunctival hamartoma (HP:0100780) | 2.53867293 |
| 53 | Hemoptysis (HP:0002105) | 2.50266104 |
| 54 | Agammaglobulinemia (HP:0004432) | 2.47687231 |
| 55 | Vacuolated lymphocytes (HP:0001922) | 2.47671494 |
| 56 | Arterial thrombosis (HP:0004420) | 2.44074227 |
| 57 | Pustule (HP:0200039) | 2.38689944 |
| 58 | Abdominal distention (HP:0003270) | 2.38433067 |
| 59 | Abnormality of the lumbar spine (HP:0100712) | 2.35889041 |
| 60 | Abnormality of the columella (HP:0009929) | 2.35381477 |
| 61 | Impaired platelet aggregation (HP:0003540) | 2.35305402 |
| 62 | Abnormal platelet function (HP:0011869) | 2.35305402 |
| 63 | Eosinophilia (HP:0001880) | 2.35301016 |
| 64 | Increased IgE level (HP:0003212) | 2.34788560 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.32216007 |
| 66 | Increased serum ferritin (HP:0003281) | 2.31319976 |
| 67 | Orchitis (HP:0100796) | 2.29978993 |
| 68 | Epistaxis (HP:0000421) | 2.29841423 |
| 69 | Petechiae (HP:0000967) | 2.29295143 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.28998850 |
| 71 | Recurrent skin infections (HP:0001581) | 2.27552845 |
| 72 | Loss of speech (HP:0002371) | 2.26518618 |
| 73 | Abnormality of the prostate (HP:0008775) | 2.25948622 |
| 74 | Gingivitis (HP:0000230) | 2.25808758 |
| 75 | Cellulitis (HP:0100658) | 2.23814879 |
| 76 | Gastrointestinal infarctions (HP:0005244) | 2.22911971 |
| 77 | Abnormality of iron homeostasis (HP:0011031) | 2.20582733 |
| 78 | Abnormality of T cells (HP:0002843) | 2.19610679 |
| 79 | Neoplasm of the rectum (HP:0100743) | 2.18298433 |
| 80 | Reduced antithrombin III activity (HP:0001976) | 2.14632385 |
| 81 | Hepatosplenomegaly (HP:0001433) | 2.14248077 |
| 82 | Abnormality of the thoracic spine (HP:0100711) | 2.13677536 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.13593202 |
| 84 | Mediastinal lymphadenopathy (HP:0100721) | 2.13499138 |
| 85 | Abnormal foot bone ossification (HP:0010675) | 2.13369365 |
| 86 | Keratoconjunctivitis (HP:0001096) | 2.12823546 |
| 87 | Neoplasm of the small intestine (HP:0100833) | 2.12433524 |
| 88 | Disinhibition (HP:0000734) | 2.11801885 |
| 89 | Flat acetabular roof (HP:0003180) | 2.11160125 |
| 90 | Verrucae (HP:0200043) | 2.08478885 |
| 91 | Papilloma (HP:0012740) | 2.08478885 |
| 92 | Esophageal varix (HP:0002040) | 2.05154791 |
| 93 | Episodic fever (HP:0001954) | 2.01571056 |
| 94 | Nasal polyposis (HP:0100582) | 2.01037542 |
| 95 | Osteolytic defects of the hand bones (HP:0009699) | 2.00650550 |
| 96 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.00650550 |
| 97 | Cerebral aneurysm (HP:0004944) | 2.00556152 |
| 98 | Viral hepatitis (HP:0006562) | 2.00117596 |
| 99 | Ureteral stenosis (HP:0000071) | 2.00113346 |
| 100 | Abnormality of the nasal mucosa (HP:0000433) | 1.99717978 |
| 101 | Abnormality of T cell physiology (HP:0011840) | 1.99058004 |
| 102 | Abnormality of the gastric mucosa (HP:0004295) | 1.98432887 |
| 103 | Urticaria (HP:0001025) | 1.97883331 |
| 104 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97776693 |
| 105 | Polygenic inheritance (HP:0010982) | 1.95395764 |
| 106 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94383709 |
| 107 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.94017653 |
| 108 | Gastrointestinal dysmotility (HP:0002579) | 1.92273144 |
| 109 | Thin bony cortex (HP:0002753) | 1.92189904 |
| 110 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.91734920 |
| 111 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.91734920 |
| 112 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.91734920 |
| 113 | Alveolar cell carcinoma (HP:0006519) | 1.91590528 |
| 114 | Hypergammaglobulinemia (HP:0010702) | 1.90434846 |
| 115 | Micronodular cirrhosis (HP:0001413) | 1.90079128 |
| 116 | Gingival bleeding (HP:0000225) | 1.89247965 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88724610 |
| 118 | Amaurosis fugax (HP:0100576) | 1.87115329 |
| 119 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86292785 |
| 120 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.86169939 |
| 121 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.85883972 |
| 122 | Mucopolysacchariduria (HP:0008155) | 1.85883972 |
| 123 | Ureteral obstruction (HP:0006000) | 1.85604955 |
| 124 | Palpitations (HP:0001962) | 1.85499841 |
| 125 | Abnormality of eosinophils (HP:0001879) | 1.82796382 |
| 126 | Hoarse voice (HP:0001609) | 1.81318348 |
| 127 | Subacute progressive viral hepatitis (HP:0006572) | 1.80319962 |
| 128 | Lymphopenia (HP:0001888) | 1.79636252 |
| 129 | Chronic obstructive pulmonary disease (HP:0006510) | 1.79441835 |
| 130 | Obstructive lung disease (HP:0006536) | 1.79441835 |
| 131 | Dysostosis multiplex (HP:0000943) | 1.79434054 |
| 132 | Polyneuropathy (HP:0001271) | 1.79219220 |
| 133 | Thickened calvaria (HP:0002684) | 1.76733995 |
| 134 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.74937925 |
| 135 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.74937925 |
| 136 | Abnormal protein glycosylation (HP:0012346) | 1.74937925 |
| 137 | Abnormal glycosylation (HP:0012345) | 1.74937925 |
| 138 | Osteomyelitis (HP:0002754) | 1.74793348 |
| 139 | Vasculitis (HP:0002633) | 1.73952712 |
| 140 | Peritonitis (HP:0002586) | 1.73938353 |
| 141 | Aortic dissection (HP:0002647) | 1.72948841 |
| 142 | Decreased circulating renin level (HP:0003351) | 1.72397744 |
| 143 | Ulnar deviation of the wrist (HP:0003049) | 1.71855150 |
| 144 | Abnormality of chloride homeostasis (HP:0011422) | 1.71018003 |
| 145 | Pulmonary infiltrates (HP:0002113) | 1.68724696 |
| 146 | Skin ulcer (HP:0200042) | 1.68515644 |
| 147 | Hyperactive renin-angiotensin system (HP:0000841) | 1.67968431 |
| 148 | Bicuspid aortic valve (HP:0001647) | 1.66608565 |
| 149 | Acute myeloid leukemia (HP:0004808) | 1.66175117 |
| 150 | Milia (HP:0001056) | 1.66064757 |
| 151 | Meningitis (HP:0001287) | 1.65349719 |
| 152 | Autoimmune hemolytic anemia (HP:0001890) | 1.65247406 |
| 153 | Goiter (HP:0000853) | 1.64623592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK10 | 4.26904902 |
| 2 | MAP3K10 | 3.74984695 |
| 3 | PRPF4B | 3.63710490 |
| 4 | FLT3 | 3.23587973 |
| 5 | TAOK3 | 3.00359421 |
| 6 | LRRK2 | 2.81325423 |
| 7 | RIPK1 | 2.44784014 |
| 8 | LMTK2 | 2.40755089 |
| 9 | PTK6 | 2.32439565 |
| 10 | ERN1 | 2.28761595 |
| 11 | IRAK3 | 2.16005905 |
| 12 | TYK2 | 2.09097387 |
| 13 | EEF2K | 2.06239038 |
| 14 | ZAP70 | 1.98612508 |
| 15 | JAK3 | 1.95544004 |
| 16 | CDK12 | 1.91248608 |
| 17 | BRSK2 | 1.90847526 |
| 18 | MAP4K1 | 1.88492004 |
| 19 | BMPR2 | 1.82949582 |
| 20 | FRK | 1.81937690 |
| 21 | IRAK4 | 1.79211366 |
| 22 | MAP3K13 | 1.78290155 |
| 23 | TRIB3 | 1.77446070 |
| 24 | MAP3K8 | 1.76362880 |
| 25 | MST4 | 1.72644042 |
| 26 | PKN2 | 1.61780760 |
| 27 | IRAK2 | 1.58177663 |
| 28 | BLK | 1.57006528 |
| 29 | KIT | 1.56848422 |
| 30 | PAK4 | 1.52678978 |
| 31 | MARK3 | 1.44357658 |
| 32 | EPHB1 | 1.43091680 |
| 33 | LATS1 | 1.39405371 |
| 34 | NME2 | 1.35023102 |
| 35 | RIPK4 | 1.31602406 |
| 36 | MAP3K14 | 1.30698954 |
| 37 | GRK6 | 1.30566991 |
| 38 | ACVR1B | 1.29885988 |
| 39 | PRKG2 | 1.29268078 |
| 40 | RPS6KA4 | 1.27116557 |
| 41 | IRAK1 | 1.27087891 |
| 42 | DYRK3 | 1.26269189 |
| 43 | BTK | 1.24899468 |
| 44 | TBK1 | 1.24607632 |
| 45 | MAP3K1 | 1.23619381 |
| 46 | TESK2 | 1.23607649 |
| 47 | MST1R | 1.21047074 |
| 48 | CSF1R | 1.18023356 |
| 49 | STK24 | 1.14085806 |
| 50 | MET | 1.13986217 |
| 51 | TAOK1 | 1.13592197 |
| 52 | STK3 | 1.07328164 |
| 53 | LYN | 1.06387360 |
| 54 | TGFBR1 | 1.06241787 |
| 55 | TAOK2 | 1.05487390 |
| 56 | WEE1 | 1.03748457 |
| 57 | MAP3K6 | 1.02262085 |
| 58 | RPS6KB2 | 1.00670655 |
| 59 | FGR | 0.99610238 |
| 60 | MAPKAPK3 | 0.97816461 |
| 61 | MAP3K5 | 0.97740307 |
| 62 | MATK | 0.96800713 |
| 63 | STK38L | 0.96662326 |
| 64 | MAP2K2 | 0.95811666 |
| 65 | MAP2K3 | 0.94976601 |
| 66 | PIM2 | 0.93295203 |
| 67 | MYLK | 0.90057410 |
| 68 | TNK2 | 0.89862777 |
| 69 | TXK | 0.88995603 |
| 70 | EPHA3 | 0.88765466 |
| 71 | PIK3CG | 0.87794058 |
| 72 | PINK1 | 0.86989931 |
| 73 | JAK2 | 0.85225731 |
| 74 | TGFBR2 | 0.83285526 |
| 75 | TESK1 | 0.83263508 |
| 76 | TEC | 0.82017156 |
| 77 | IKBKB | 0.81961513 |
| 78 | LATS2 | 0.80002118 |
| 79 | JAK1 | 0.79125929 |
| 80 | MAP3K11 | 0.78790626 |
| 81 | KDR | 0.77153212 |
| 82 | MAPKAPK2 | 0.76457194 |
| 83 | DMPK | 0.76129753 |
| 84 | MAP2K6 | 0.74544024 |
| 85 | SYK | 0.74369933 |
| 86 | ITK | 0.70645567 |
| 87 | BRD4 | 0.70598336 |
| 88 | EPHB2 | 0.70277207 |
| 89 | HIPK2 | 0.70216907 |
| 90 | GRK7 | 0.68530337 |
| 91 | RPS6KA2 | 0.67231221 |
| 92 | YES1 | 0.67121552 |
| 93 | CAMK1D | 0.66492836 |
| 94 | CHUK | 0.65488362 |
| 95 | NME1 | 0.64705700 |
| 96 | MAP3K3 | 0.63361901 |
| 97 | PTK2 | 0.63121739 |
| 98 | MOS | 0.62952300 |
| 99 | MAPK7 | 0.61046409 |
| 100 | CDK6 | 0.60636199 |
| 101 | CLK1 | 0.59327042 |
| 102 | PRKCQ | 0.58995262 |
| 103 | PDPK1 | 0.57917256 |
| 104 | MAP3K7 | 0.57824559 |
| 105 | MAPK12 | 0.57123311 |
| 106 | BMPR1B | 0.56451885 |
| 107 | GSK3A | 0.55818652 |
| 108 | CDC42BPA | 0.55550256 |
| 109 | PDK1 | 0.54915473 |
| 110 | IKBKE | 0.54792987 |
| 111 | CSK | 0.54062740 |
| 112 | PIM1 | 0.53268953 |
| 113 | NEK2 | 0.52968174 |
| 114 | PRKAA2 | 0.47296192 |
| 115 | OXSR1 | 0.45769353 |
| 116 | FGFR3 | 0.44559944 |
| 117 | MARK2 | 0.43767497 |
| 118 | LCK | 0.41144632 |
| 119 | RPS6KL1 | 0.38972584 |
| 120 | RPS6KC1 | 0.38972584 |
| 121 | MAPK11 | 0.38735124 |
| 122 | TTN | 0.38646214 |
| 123 | PDGFRB | 0.37736536 |
| 124 | MAPK3 | 0.36668143 |
| 125 | EGFR | 0.35490893 |
| 126 | PAK1 | 0.35421013 |
| 127 | STK39 | 0.34807637 |
| 128 | ABL1 | 0.34124884 |
| 129 | STK4 | 0.33498441 |
| 130 | RPS6KA6 | 0.33225546 |
| 131 | MELK | 0.32701786 |
| 132 | TRPM7 | 0.32154294 |
| 133 | CDC7 | 0.32105292 |
| 134 | FES | 0.31193367 |
| 135 | RPS6KA1 | 0.31055126 |
| 136 | PRKCD | 0.30788064 |
| 137 | FGFR4 | 0.30660102 |
| 138 | NTRK1 | 0.30415164 |
| 139 | MAPK4 | 0.30013400 |
| 140 | CDK4 | 0.29111154 |
| 141 | SIK1 | 0.28757939 |
| 142 | HCK | 0.27962694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.62220835 |
| 2 | Asthma_Homo sapiens_hsa05310 | 2.35404553 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.19151001 |
| 4 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.10524753 |
| 5 | * Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.04067589 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.02204220 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.97534672 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.96153401 |
| 9 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.95718935 |
| 10 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.95628751 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.85397198 |
| 12 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.77685297 |
| 13 | Mineral absorption_Homo sapiens_hsa04978 | 1.77343423 |
| 14 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.73760786 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.73700995 |
| 16 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.71167739 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69638845 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.64731983 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.59279439 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.58331046 |
| 21 | Allograft rejection_Homo sapiens_hsa05330 | 1.58213411 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.55833582 |
| 23 | Apoptosis_Homo sapiens_hsa04210 | 1.55751161 |
| 24 | Galactose metabolism_Homo sapiens_hsa00052 | 1.52173113 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51110704 |
| 26 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.50963932 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.49559570 |
| 28 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.46965033 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.42884476 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.41700281 |
| 31 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.35287558 |
| 32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.33528889 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.31828180 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30950052 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.29983717 |
| 36 | Measles_Homo sapiens_hsa05162 | 1.28590379 |
| 37 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.27363770 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.27283203 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.25802752 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.25550300 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25416714 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22872157 |
| 43 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.21691802 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20922629 |
| 45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.20356678 |
| 46 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.19583928 |
| 47 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.17718016 |
| 48 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.15260123 |
| 49 | Lysosome_Homo sapiens_hsa04142 | 1.13685873 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13301825 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 1.11480567 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09764877 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 1.08488984 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07353197 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.05572402 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04468321 |
| 57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02830101 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02754267 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01865894 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 1.01550604 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99880082 |
| 62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.99173014 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.97580117 |
| 64 | Cell cycle_Homo sapiens_hsa04110 | 0.97187448 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96116002 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95608314 |
| 67 | Thyroid cancer_Homo sapiens_hsa05216 | 0.95129247 |
| 68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.93683009 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92997941 |
| 70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90848883 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89823360 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88522554 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86041484 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.81032417 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.80897578 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.80229146 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79826724 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79743451 |
| 79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.79373400 |
| 80 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76942830 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76721053 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76085305 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72927350 |
| 84 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72416667 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.72326354 |
| 86 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71508635 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.71281769 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70645581 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.70116547 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69663921 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67742089 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66825261 |
| 93 | DNA replication_Homo sapiens_hsa03030 | 0.63537952 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62718053 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.61988434 |
| 96 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.60726029 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60468468 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59436330 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57987694 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57906296 |
| 101 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.57287431 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.55602409 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55550717 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54016467 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53290418 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52874190 |
| 107 | Adherens junction_Homo sapiens_hsa04520 | 0.51159888 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50934286 |
| 109 | Prostate cancer_Homo sapiens_hsa05215 | 0.50241894 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.50215581 |
| 111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50108273 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47217011 |
| 113 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46532797 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46243804 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.45795945 |
| 116 | Focal adhesion_Homo sapiens_hsa04510 | 0.45759688 |
| 117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45591446 |
| 118 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44472779 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44303110 |
| 120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42072326 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41917543 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40893778 |
| 123 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40224513 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39651499 |
| 125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38478806 |
| 126 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38101281 |
| 127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36882426 |
| 128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36735230 |
| 129 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36247195 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.36205350 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33871128 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33823765 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33362553 |
| 134 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29650732 |

